Molecular diagnosis of lymphoid malignancies by gene expression profiling

Current Opinion in Hematology

Volumn 9, Issue 4, 2002, Pages 333-338

  Davis, R Eric ^a   Staudt, Louis M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; DNA; TUMOR PROTEIN;

APOPTOSIS; B CELL LYMPHOMA; CANCER DIAGNOSIS; CANCER STAGING; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; DISEASE COURSE; DNA MICROARRAY; GENE EXPRESSION; GENOME; HUMAN; LEUKEMIA; LYMPHATIC LEUKEMIA; LYMPHOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW; GENE EXPRESSION PROFILING; GENETICS; METABOLISM;

DNA, NEOPLASM; GENE EXPRESSION PROFILING; HUMAN; LYMPHOMA; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; HUMANS;

EID: 0036015003     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200207000-00011     Document Type: Review

References (24)

1. Diffuse large cell lymphoma
2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
3. Cluster analysis and display of genome-wide expression patterns
4. Clonal evolution of a follicular lymphoma: Evidence for antigen selection
5. Signatures of the immune response
6. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
7. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas
8. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans
9. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma (DLBCL) with a germinal center B-cell gene expression profile
10. Constitutive nuclear factor kappa-B activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
11. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma
12. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
13. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
14. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia
15. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells
16. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
17. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism
18. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases
19. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia
20. Gene expression signatures define novel oncogenic pathways in T-cell acute lymphoblastic leukemia
21. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB
22. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity
23. Proteasome inhibition in cancer: Development of PS-341